The efficacy of treatment versus the prevalence of the condition in Black patients adds evidence to the pile that more diversity is needed in clinical trials.
Racial Bias and Equity
Racial disparities in health outcomes have largely been shown to stem from structural racism and social determinants of health — factors such as inequitable access to economic opportunity, quality education, affordable and healthy foods, and a safe community. While the responsibility of eliminating racial disparities is shared also by the community and policymakers, healthcare providers can have immense impact through research, care models, training, and advocacy.
A new collaboration among Boston cancer centers aims to increase minority populations’ access to the latest treatments for more equitable outcomes.
Boston’s Black women die from breast cancer in higher rates than any other group. The area’s major medical systems are collaborating to break down structures driving the disparity.
While reasons patients avoid addiction care are complex, providers are modeling the ample opportunity clinics have to engage underrepresented groups.
Structural racism has neglected generations’ suffering from sickle cell disease. Novel therapies are on the horizon, but can they affordably be brought to the masses?